CGW Clinical Genomics Workspace
Comprehensive genomic analysis and reporting platform for precision medicine
Platform · Cloud SaaSCompany source
Company profile
About Pierian
Pierian is a precision medicine technology company that develops clinical genomics interpretation and reporting software for healthcare organizations, laboratories, and research institutions. The company's flagship product, Clinical Genomics Workspace (CGW), is a comprehensive platform designed to streamline the analysis and interpretation of genomic data for oncology and rare disease applications. Pierian's software enables clinical laboratories to transform complex genomic sequencing data into actionable clinical reports that support precision medicine decision-making. The platform integrates advanced bioinformatics tools with clinical knowledge bases to help genomic specialists identify clinically relevant variants, assess their significance, and generate reports that meet regulatory and clinical standards. Pierian serves molecular diagnostic laboratories, academic medical centers, hospital systems, and pharmaceutical companies involved in genomic testing and precision oncology. The company's technology addresses the growing need for scalable, efficient genomic interpretation solutions as next-generation sequencing becomes increasingly integrated into routine clinical care. By automating portions of the interpretation workflow while maintaining clinical oversight, Pierian helps organizations increase throughput, reduce turnaround times, and improve consistency in genomic reporting.
Company description Pierian official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Pierian?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cancer
- oncology
- rare diseases
Who it serves
- academic medical centers
- hospital systems
- molecular diagnostic laboratories
- pharmaceutical companies
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
Company milestones
Platform expansion
Company rebranded from PierianDx to Pierian
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.The Journal of investigative dermatology · Dec 1, 2018
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia.Haematologica · Apr 1, 2017
Identification of Medically Actionable Secondary Findings in the 1000 Genomes.PloS one · Jan 1, 2015
Evaluation of a community arts installation event in support of public health.Perspectives in public health · Jan 1, 2015
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Pierian
Recent articles published on Pierian's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.